You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atezolizumab

Showing 1 - 25 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial (Atezolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • Atezolizumab
  • (no location specified)
Oct 3, 2023

Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Atezolizumab
  • +2 more
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital at Linkou
Nov 17, 2023

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Atezolizumab
  • +2 more
  • Athens, Greece
  • +1 more
Sep 16, 2023

Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • all trans Retinoic Acid
  • +2 more
  • (no location specified)
Aug 11, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

Not yet recruiting
  • Locally Advanced Solid Tumors
  • +2 more
  • (no location specified)
Sep 4, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Atezolizumab
  • +3 more
  • (no location specified)
Jun 14, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Atezolizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Grenoble, France
    University Hospital
Dec 23, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Apr 11, 2023

Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)

Recruiting
  • Stage II Melanoma
  • Atezolizumab
  • +2 more
  • Duarte, California
  • +5 more
Nov 10, 2022

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Atezolizumab
  • +2 more
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 16, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
Nov 2, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023